Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anupa John
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital
Observed institutions:
Manipal Academy of Higher Education,
Homi Bhabha National Institute,
Tata Memorial Hospital,
Kasturba Medical College Hospital,
Kasturba Medical College, Manipal
ORCID:
0000-0001-6691-2668
Observed ORCID:
0000-0001-6691-2668
OpenAlex ID:
A5011935385
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India
2024
·
Vamshi Krishna Muddu
, Anjali Shah
, et al.
·
JCO Global Oncology
·
13
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC
2023
·
Vanita Noronha
, Nandini S. Menon
, et al.
·
JTO Clinical and Research Reports
·
12
PDF
Amivantamab: A narrative drug review
2023
·
Anupa John
, Vanita Noronha
, et al.
·
Cancer Research Statistics and Treatment
·
8
Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India
2021
·
Nitin Gupta
, Anupa John
, et al.
·
Drug Discoveries & Therapeutics
·
8
PDF
Implementation of a CAR-T cell therapy program in India
2025
·
Hema Hotchandani
, Manju Sengar
, et al.
·
Expert Review of Anticancer Therapy
·
7
A prospective observational study to compare the efficacy, time toxicity, and cost of conventional 3+7 regimen versus azacitidine + venetoclax (AZA + VEN) as induction therapy in patients with acute myeloid leukemia (AML).
2026
·
Manju Sengar
, Arvind Vaidyanathan
, et al.
·
Journal of Clinical Oncology
·
2
Paraparesis in a patient with advanced HIV infection: a diagnostic conundrum
2021
·
Anupa John
, Nitin Gupta
, et al.
·
BMJ Case Reports
·
2
Safety and feasibility of outpatient induction with intensive monitoring in AML: pilot study and extension cohort
2026
·
Hasmukh Jain
, Alok Shetty
, et al.
·
Blood Global Hematology
·
1
PDF
Efficacy and safety of taxane platinum doublet chemotherapy with triple oral metronomic chemotherapy and low dose nivolumab as neoadjuvant therapy in locally advanced head and neck squamous cell carcinoma.
2025
·
Shriraj Shailesh Talati
, Minit Jalan Shah
, et al.
·
Journal of Clinical Oncology
·
1
PDF
ALL-772: Efficacy of Inotuzumab Ozogamicin When Used as Salvage/Bridging Therapy Prior to CD19-Directed CAR-T Therapy in Relapsed/Refractory B-ALL: A Single-Center Experience
2026
·
Anupa John
, Alok Shetty
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ALL-772: Efficacy of Inotuzumab Ozogamicin When Used as Salvage/Bridging Therapy Prior to CD19-Directed CAR-T Therapy in Relapsed/Refractory B-ALL: A Single-Center Experience
2026
·
Anupa John
, Alok Shetty
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-570: Early Experience With Glofitamab Plus Polatuzumab Vedotin as Bridging Therapy Prior to CD19-Directed CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
2026
·
Yash Shah
, Thomas Eipe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-570: Early Experience With Glofitamab Plus Polatuzumab Vedotin as Bridging Therapy Prior to CD19-Directed CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
2026
·
Yash Shah
, Thomas Eipe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety
2026
·
Atharva Karulkar
, Hasmukh Jain
, et al.
·
Blood Cancer Journal
PDF
Genomic profiling of Burkitt lymphoma in adults: Novel molecular insights and implications for outcomes.
2026
·
Manju Sengar
, Epari Sridhar
, et al.
·
Journal of Clinical Oncology
PDF
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium
2026
·
Colin J. Thomas
, Min Jung Koh
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Risk of Hepatitis B Reactivation Among ALL Patients With Occult Hepatitis B Infection
2026
·
Hasmukh Jain
, Neha Sharma
, et al.
·
JCO Global Oncology
PDF
CT-1080: Incidence, Clinical Characteristics, and Risk Factors of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (IEC-HS) in Patients Treated With Talicabtagene Autoleucel (Humanized Anti-CD19 CAR-T)
2025
·
Hema Hotchandani
, Devanshi Kalra
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-1080 Incidence, Clinical Characteristics, and Risk Factors of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (IECHS) in Patients Treated With Talicabtagene Autoleucel (Humanized Anti-CD19 CAR-T)
2025
·
Hema Hotchandani
, Devanshi Kalra
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Effect of Type 2 Diabetes on Bone Mineral Density: A Prospective Observational Study
2025
·
Sindhu Sujeeth Hegde
, Anupa John
, et al.
·
APIK Journal of Internal Medicine
Authors’ reply to Shah and Sahu
2023
·
Anupa John
, Vanita Noronha
, et al.
·
Cancer Research Statistics and Treatment
A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell lung cancer.
2023
·
Nandini Sharrel Menon
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
22
Citation count:
54
H-index:
5
I10-index:
2
Year
Topic
Type